Free access
Issue
Vet. Res.
Volume 41, Number 1, January-February 2010
Number of page(s) 14
DOI http://dx.doi.org/10.1051/vetres/2009053
Published online 24 September 2009
How to cite this article Vet. Res. (2010) 41:05
References of  Vet. Res. (2010) 41:05
  1. Botsford J.L., Harman J.G., Cyclic AMP in prokaryotes, Microbiol. Rev. (1992) 56:100–122 [PubMed].
  2. Busby S., Ebright R.H., Transcription activation by catabolite activator protein (CAP), J. Mol. Biol. (1999) 293:199–213 [CrossRef] [PubMed].
  3. Carnell S.C., Bowen A., Morgan E., Maskell D.J., Wallis T.S., Stevens M.P., Role in virulence and protective efficacy in pigs of Salmonella enterica serovar Typhimurium secreted components identified by signature-tagged mutagenesis, Microbiology (2007) 153:1940–1952 [CrossRef] [PubMed].
  4. Chang C.C., Lin Y.H., Chang C.F., Yeh K.S., Chiu C.H., Chu C., et al., Epidemiologic relationship between fluoroquinolone-resistant Salmonella enterica serovar Choleraesuis strains isolated from humans and pigs in Taiwan (1997 to 2002), J. Clin. Microbiol. (2005) 43:2798–2804 [CrossRef] [PubMed].
  5. Chien M.S., Chan Y.Y., Chen Z.W., Wu C.M., Liao J.W., Chen T.H., et al., Actinobacillus pleuropneumoniae serotype 10 derived ApxI induces apoptosis in porcine alveolar macrophages, Vet. Microbiol. (2009) 135:327–333 [CrossRef] [PubMed].
  6. Chiu C.H., Wu T.L., Su L.H., Chu C., Chia J.H., Kuo A.J., et al., The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, N. Engl. J. Med. (2002) 346:413–419 [CrossRef] [PubMed].
  7. Chiu C.H., Chuang C.H., Chiu S., Su L.H., Lin T.Y., Salmonella enterica serotype Choleraesuis infections in pediatric patients, Pediatrics (2006) 117:e1193–e1196.
  8. Chu C.Y., Wang S.Y., Chen Z.W., Chien M.S., Huang J.P., Chen J.J., et al., Heterologous protection in pigs induced by a plasmid-cured and crp genedeleted Salmonella choleraesuis live vaccine, Vaccine (2007) 25:7031–7040 [CrossRef] [PubMed].
  9. Curtiss R. III, Goldschmidt R.M., Fletchall N.B., Kelly S.M., Avirulent Salmonella typhimurium $\Delta$cya $\Delta$crp oral vaccine strains expressing a streptococcal colonization and virulence antigen, Vaccine (1988) 6:155–160 [CrossRef] [PubMed].
  10. Elsinghorst E.A., Measurement of invasion by gentamicin resistance, Methods Enzymol. (1994) 236:405–420 [PubMed].
  11. Fedorka-Cray P.J., Kelley L.C., Stabel T.J., Gray J.T., Laufer J.A., Alternate routes of invasion may affect pathogenesis of Salmonella typhimurium in swine, Infect. Immun. (1995) 63:2658–2664 [PubMed].
  12. Fields P.I., Swanson R.V., Haidaris C.G., Heffron F., Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent, Proc. Natl. Acad. Sci. USA (1986) 83:5189–5193 [CrossRef] [PubMed].
  13. Galan J.E., Curtiss R. III, Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells, Proc. Natl. Acad. Sci. USA (1989) 86:6383–6387 [CrossRef] [PubMed].
  14. Galan J.E., Curtiss R. III, Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling, Infect. Immun. (1990) 58:1879–1885 [PubMed].
  15. Hackett J., Salmonella-based vaccines, vaccine (1990) 8:5–11.
  16. Hersh D., Monack D.M., Smith M.R., Ghori N., Falkow S., Zychlinsky A., The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1, Proc. Natl. Acad. Sci. USA (1999) 96:2396–2401 [CrossRef] [PubMed].
  17. Hoiseth S.K., Stocker B.A., Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines, Nature (1981) 291:238–239 [CrossRef] [PubMed].
  18. Iglesias G., Pijoan C., Molitor T., Interactions of Pseudorabies virus with swine alveolar macrophages I: virus replication, Arch. Virol. (1989) 104:107–115 [CrossRef] [PubMed].
  19. Kelly S.M., Bosecker B.A., Curtiss R. III, Characterization and protective properties of attenuated mutants of Salmonella choleraesuis, Infect. Immun. (1992) 60:4881–4890 [PubMed].
  20. Kennedy M.J., Yancey R.J. Jr, Sanchez M.S., Rzepkowski R.A., Kelly S.M., Curtiss R. III, Attenuation and immunogenicity of Dcya $\Delta$crp derivatives of Salmonella choleraesuis in pigs, Infect. Immun. (1999) 67:4628–4636 [PubMed].
  21. Ku Y.W., McDonough S.P., Palaniappan R.U., Chang C.F., Chang Y.F., Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis, Infect. Immun. (2005) 73:8194–8203 [CrossRef] [PubMed].
  22. Lawson C.L., Swigon D., Murakami K.S., Darst S.A., Berman H.M., Ebright R.H., Catabolite activator protein: DNA binding and transcription activation, Curr. Opin. Struct. Biol. (2004) 14:10–20 [CrossRef] [PubMed].
  23. Meeusen E.N., Walker J., Peters A., Pastoret P.P., Jungersen G., Current status of veterinary vaccines, Clin. Microbiol. Rev. (2007) 20:489–510 [CrossRef] [PubMed].
  24. Miller V.L., Mekalanos J.J., A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR, J. Bacteriol. (1988) 170:2575–2583 [PubMed].
  25. Monack D.M., Raupach B., Hromockyj A.E., Falkow S., Salmonella typhimurium invasion induces apoptosis in infected macrophages, Proc. Natl. Acad. Sci. USA (1996) 93:9833–9838 [CrossRef] [PubMed].
  26. Monack D.M., Hersh D., Ghori N., Bouley D., Zychlinsky A., Falkow S., Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model, J. Exp. Med. (2000) 192:249–258 [CrossRef] [PubMed].
  27. Nnalue N.A., Stocker B.A., Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis, Infect. Immun. (1987) 55:955–962 [PubMed].
  28. Patel J.C., Galan J.E., Investigating the function of Rho family GTPases during Salmonella/host cell interactions, Methods Enzymol. (2008) 439:145–158 [PubMed].
  29. Petersen S., Young G.M., Essential role for cyclic AMP and its receptor protein in Yersinia enterocolitica virulence, Infect. Immun. (2002) 70:3665–3672 [CrossRef] [PubMed].
  30. Reed L.J., Muench H., A simple method of estimating fifty percent endpoints, Am. J. Hyg. (1938) 27:493–497.
  31. Schlumberger M.C., Hardt W.D., Salmonella type III secretion effectors: pulling the host cell's strings, Curr. Opin. Microbiol. (2006) 9:46–54 [CrossRef] [PubMed].
  32. Schwartz K.J., Salmonellosis, in: Straw B.E., D'Allaire S., Mengeling W., Taylor D.J. (Eds.), Disease of swine, 8th ed., Iowa State University Press, Ames, 1999, pp. 535–551.
  33. Sheoran A.S., Timoney J.F., Tinge S.A., Sundaram P., Curtiss R. III, Intranasal immunogenicity of a $\Delta$cya $\Delta$crp-pabA mutant of Salmonella enterica serotype Typhimurium for the horse, Vaccine (2001) 19:3787–3795 [CrossRef] [PubMed].
  34. Stabel T.J., Mayfield J.E., Morfitt D.C., Wannemuehler M.J., Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [ $\Delta$cya-12 $\Delta$(crp-cdt)19] mutant containing a recombinant plasmid, Infect. Immun. (1993) 61:610–618 [PubMed].
  35. Tacket C.O., Hone D.M., Curtiss R. III, Kelly S.M., Losonsky G., Guers L., et al., Comparison of the safety and immunogenicity of $\Delta$aroC $\Delta$aroD and $\Delta$cya $\Delta$crp Salmonella typhi strains in adult volunteers, Infect. Immun. (1992) 60:536–541 [PubMed].
  36. Tartera C., Metcalf E.S., Osmolarity and growth phase overlap in regulation of Salmonella typhi adherence to and invasion of human intestinal cells, Infect. Immun. (1993) 61:3084–3089 [PubMed].
  37. Teplitski M., Goodier R.I., Ahmer B.M., Catabolite repression of the SirA regulatory cascade in Salmonella enterica, Int. J. Med. Microbiol. (2006) 296:449–466 [CrossRef] [PubMed].
  38. Van der Velden A.W., Lindgren S.W., Worley M.J., Heffron F., Salmonella pathogenicity island 1-independent induction of apoptosis in infected macrophages by Salmonella enterica serotype Typhimurium, Infect. Immun. (2000) 68:5702–5709 [CrossRef] [PubMed].
  39. Vazquez-Torres A., Jones-Carson J., Baumler A.J., Falkow S., Valdivia R., Brown W., et al., Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes, Nature (1999) 401:804–808 [CrossRef] [PubMed].
  40. Yeh K.S., Hancox L.S., Clegg S., Construction and characterization of a fimZ mutant of Salmonella typhimurium, J. Bacteriol. (1995) 177:6861–6865 [PubMed].
  41. Yoon H., McDermott J.E., Porwollik S., McClelland M., Heffron F., Coordinated regulation of virulence during systemic infection of Salmonella enterica serovar Typhimurium, PLoS Pathog. (2009) 5:e1000306.
  42. Zhang S., Kingsley R.A., Santos R.L., Andrews-Polymenis H., Raffatellu M., Figueiredo J., et al., Molecular pathogenesis of Salmonella enterica serotype Typhimurium-induced diarrhea, Infect. Immun. (2003) 71:1–12 [CrossRef] [PubMed].
  43. Zhang X., Kelly S.M., Bollen W.S., Curtiss R. III, Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 $\Delta$crp and $\Delta$cdt deletion mutants, Infect. Immun. (1997) 65:5381–5387 [PubMed].
  44. Zhang Y., Buchholz F., Muyrers J.P., Stewart A.F., A new logic for DNA engineering using recombination in Escherichia coli, Nat. Genet. (1998) 20:123–128 [CrossRef] [PubMed].
  45. Zhou D., Galan J., Salmonella entry into host cells: the work in concert of type III secreted effector proteins, Microbes Infect. (2001) 3:1293–1298 [CrossRef] [PubMed].